ANIKA WILSON: Open Payments
NPI 1306055330 · MADISON, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,492 in 143 payments from 17 companies in 2025. Trend: 2023 $3,798 · 2024 $3,051 · 2025 $2,492
Food & beverage: $2,492
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $584 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 38 | $531 |
| Corium, LLC | 20 | $279 |
| Otsuka America Pharmaceutical, Inc. | 11 | $277 |
| Tris Pharma Inc | 12 | $181 |
| Alkermes, Inc. | 9 | $159 |
| Vanda Pharmaceuticals Inc. | 5 | $111 |
| Axsome Therapeutics, Inc. | 4 | $68 |
| Lundbeck LLC | 3 | $67 |
| Janssen Pharmaceuticals, Inc | 3 | $63 |
Products named: VRAYLAR, CAPLYTA, Azstarys, REXULTI, Dyanavel XR, ARISTADA, FANAPT, Auvelity.
Industry payments across AL — which companies pay providers there.
